though NK cells and T cells share a number of biological functions including cytotoxicity and lymphokine secretion (1), they appear to differ fundamentally in the structure of their antigen receptors. Whereas T cells are known to recognize foreign antigens via their CD3-associated heterodimeric ce/15 or 3'/g TCK, the antigen recognition structures used by NK cells are still in the process of being ducidated. In this respect, current evidence (2) (3) (4) (5) suggests that NK cells express polymorphic (but nonrearranging) receptors that bdoug to the NKR-Pl and Ly-49 families in mouse and the recently doned p58 family in humans. The nature of the ligands recognized by NK cells is controversial, although there is functional evidence that both Ly-49 and p58 receptor families may mediate negative signals upon engagement of particular MHC class I alleles (2) (3) (4) (5) . In contrast, NKK-Pl receptors appear to bind to a heterogeneous group of carbohydrate ligands (6) , thereby triggering effector functions such as cytolysis (6, 7) .
NK and T cells probably arise from related but distinct developmental lineages (8) . Whereas the majority of ce//3 or ~///~ T cells depend upon the thymus for their development, NK cells develop normally in athymic (nude) mice. Furthermore, recombination-deficient mutant (RAG-/-or SCID) mice have normal levels of NK cells despite the complete absence of ce/B or "y//~ T cells. Nevertheless, it is likely that both NK and T cells arise from a common "lymphoid committed" precursor cell, since both lineages (as weU as B cells) are absent in mice lacking the ikaros transcription factor, whereas other hematopoietic cells develop normally in these mutant mice (9) .
In view of the apparently distinct ligands recognized by NK cells and T cells, it is of considerable interest that a subset oflymphocytes sharing receptor structures common to both lineages has been identified in mice (10) (11) (12) , rats (13) , and humans (14, 15) . In the mouse, the best-defined such population coexpresses the ce/B TCR and NKI.1 (16) (a member of the NKR-Pl family), although other subsets of mouse TCR-cx/fl cells expressing members of the Ly-49 family have been described (17, 18) . This commentary will focus on NKI.1 + TCK-odfl + (hereafter referred to as NK1 + T) cells and, in particular, will summarize recent insights into their origin, specificity, and function.
Phenotype and TCR Expression of NKI + T Cells
The surface phenotype of NK1 + T cells is dramatically different from that of normal ce/fl T cells. As summarized in (19) , and a single Vex domain (Vcd4) is highly overrepresented among NK1 + T cells but rarely used by conventional r T cells (20) . The latter finding explains the earlier puzzling observations of Taniguchi and co-workers (21) , who identified a subset of peripheral T cells expressing an invariant Vol14-Jc~281 rearrangement with no junctional diversity. These Ipr/gld T cells resemble NK1 + T cells in that they are TCR i"t and express certain activation markers such as CD44hish; however, they differ phenotypically from NK1 + T cells in that they express the B cell marker B220 and fail to express NKI.1 (Table 1) . Furthermore, lpr/gld T cells and NK1 + T cells differ fundamentally in their TCR repertoires (Table 1) 
Relationship of NKI + T Cells to TCR int

Developmental Origin of NK1 + T Cells
The developmental origin of NK1 § T cells is controversial. Historically, a T cell subset corresponding phenotypically to NK1 + T cells was first identified among CD4-8-thymocytes (24, 25) , although it was not appreciated for some time that these cells actually express NKI.1 (11) . Subsequently, NK1 + T ceils were observed in other lymphoid organs such as spleen (10) and bone marrow (12) as well as in liver (26) . NK1 + T cells resident in the thymus appear to develop in situ, since cells of the NKI.1 + TCR-ot/3 + phenotype can be generated in fetal thymus organ cultures established from 14-d mouse embryos (27) . Furthermore, neonatal thymus grafts implanted in congenitally athymic (nude) mice can give rise to small numbers of NK1 + T cells in recipient bone marrow and spleen (28) , suggesting a thymus-dependent origin for at least some peripheral NK1 + T cells. Nevertheless, NKI.1 + TCR-al3 + cells are readily detectable in extrathymic tissues such as bone marrow (12) , spleen (29) , and liver (30) of nude mice. Thus, it appears that NK1 + T cells can be of either thymus-dependent or -independent origin. This conclusion is compatible with the finding that NK1 + T cells require expression of an endogenous ligand on hematopoietic cells (but not specialized epithelial cells) for their development (26, 27, 31) .
New evidence for the extrathymic origin of at least some NK1 + T cells is presented by Sato et al. in this issue (22) . In particular, these authors show that NK1 + T cells (and other TCR i~t cells) develop selectively in the liver and spleen of thymectomized irradiated F1 mice reconstituted with parental or syngeneic bone marrow cells. In control (euthymic) irradiated mice, both NK1 + T and conventional (TCR hiSh) T cells develop in these organs; however, the development of normal T cells is delayed relative to NK1 + T cells. The bone marrow precursors of NK1 + T cells in this adoptive transfer system express Thy-1 but not the TCR-CD3 complex. The findings of Sato et al. (22) are reminiscent of earlier reports in which TCR-c~/3 + cells were shown to be generated in vitro from bone marrow precursors (32-34); however, a very recent study indicates that most TCR-a/3 + cells produced in short-term bone marrow cultures from Thy-1 + TCK-a/fl-precursors are in fact NKI.1- (35) .
If NK1 + T ceils do indeed arise extrathymically, it should in theory be possible to demonstrate activity of the recombinase-activating genes (RAGs) (which are essential for TCR rearrangement) in NK1 + T precursor cells in the corresponding tissues. In this regard, RAG-1 and RAG-2 messenger KNA have been detected previously by PCR in liver mononuclear ceils (36) ; however, no RAG-1 transcripts could be detected in liver by Northern blot in a subsequent study (37) . Interestingly, Sato et al. (22) find that RAG-1 transcripts are expressed at much higher levels among liver mononuclear cells of reconstituted radiation bone marrow chimeras than in normal mouse liver. These data are consistent with an increased rate of extrathymic TCK-a/fl rearrangement in NK1 + T cell precursors in the chimeric animals.
Ligand Specificity of NK1 + T Cells
As mentioned above, most NK1 + T ceils express a TCK with a limited fl chain (V~8.2, Vfl7, or Vfl2) and virtually invariant a chain (Va14-Jot281) usage. It therefore seems likdy that the ligand(s) for this TCK will be highly restricted (or even monomorphic). Several experiments in vivo using genetargeted "knockout" mice have provided dues as to the potential ligands that control NK1 + T ceil development. Thus, it is dear that NK1 + T cells in thymus (27, 31, 38) or liver (26) , as well as the related Vot14 + peripheral T cell subset (39), fail to develop in fl2-microglobulin (fl2-m)-deficient mice, suggesting that a flzm-assodated (i.e., MHC class I or rdated) molecule is a component of the ligand of the NK1 + T cell receptor. Further insight into the nature of this putative ligand comes from recent analysis of mice deficient for the peptide transporter-associated protein 1 (TAP-l). In these mice, which lack conventional MHC class I molecules (H-2K, D and L), Vc~14 + T cells (and hence, presumably, most NK1 + T cells) develop normally (39) . Taken together, the data with mutant mice suggest that NK1 + T cells recognize a flzm-assodated molecule that does not require peptides transported by TAP-1 for its assembly and surface expression. Interestingly, there are at least two wdl-characterized molecules that fulfill these criteria: the thymus leukemia antigen (40) and CD1 (41) . In this context, Taniguchi and coworkers have identified a wild mouse strain in which Vcd4 + T cells do not devdop. In F2 backcross analysis, this defect segregates as a single recessive gene that is unlinked to the MHC (39). If, indeed, the absence of Val4 + ceils in these wild mice reflects a defect in the ligand responsible for NK1 + T cell development, then it follows that the thymus leukemia antigen (which is dosdy linked to the MHC) cannot be the relevant ligand.
The case favoring CD1 as a potential ligand for NK1 + T cdls has been greatly strengthened by very recent analysis of the specificity of NK1 + T hybridomas. Thus, Bendelac et al. (42) demonstrated that several hybridomas bearing the invariant Vc~14-Jc~281 rearrangement could be stimulated to produce lymphokines in vitro after exposure to CD1-expressing thymocytes or fibroblasts infected with a vaccinia construct containing the mouse CD1 gene. Furthermore, this stimulation could be inhibited by mAbs to either the TCK or to CD1. Weaker reactivity of freshly isolated normal thymic NK1 § T cells to CDl-expressing fibroblasts could also be demonstrated. These data provide the first convincing evidence that CD1 is a component of the physiological ligand recognized by the TCK on NK1 + T ceils. It will be of great interest to determine whether CD1 can associate with peptides or other nonpeptidic moieties to stimulate NK1 + T cells. In this respect, it is known that some human TCKodfl + clones can recognize mycolic acid (a mycobacterial ceil waU product) in association with CDlb (43) .
In considering the possible ligands recognized by NK1 + T cells, it should be emphasized that the potential contribution of the NKI.1 molecule itself to ligand specificity cannot be discounted. Indeed, NKI.1 is a member of the NKK-Pl family of C-type (calcium-dependent) lectins, and there is evidence that at least some members of this family may interact with complex oligosaccharides present on the surface of certain "NK-susceptible" target cells (6) . In conventional NK cdls, this interaction apparently leads to activation of the cytolytic program (6, 7). Furthermore, both NK cells (2) and activated NK1 + T cells (44) are capable of redirected lysis of Fc receptor-bearing target ceils in the presence of anti-NKI.1 antibodies. Collectivdy, these data raise the possibility that the NKI.1 molecule on NK1 + T cells (or another NKR-Pl family member) may confer specificity for an oligosaccharide ligand and/or a carbohydrate component of a complex ligand (perhaps involving CD1) that is corecognized by the ot/fl TCR. In the latter case, NKI.1 could be considered as a type of coreceptor molecule that modifies the avidity of TCR-ligand interactions on NK1 + T ceils. This speculative model (Fig. 1) is further supported by the fact that the cytoplasmic domains of NKR-P1 family members share a motif (Cys-X-Cys-Pro) that has been shown to be involved in the association of CD4 and CD8 coreceptors with the tyrosine kinase p561ck (2). However, no direct evidence for a molecular association between p561ck and NKI.1 has been reported.
Function of NK1 + T Cells
Because of the lack of precise knowledge of their ligand specificity, the function of NK1 + T ceils under physiological conditions has been difficult to address. However, the functional potential of NK1 + T cells has been investigated in vivo and in vitro by triggering their TCK-CD3 complex with mAbs. Such studies have shown a remarkable ability of NK1 + T cells to produce large amounts of cytokines and, in particular, IL-4. Indeed, it is likely that virtually all the IL-4 produced in vitro by anti-CD3-stimulated thymocytes can be accounted for by the NKI.1 + T subset (45, 46) , and similar conclusions have been reached for splenic T ceUs from normal mice injected with anti-CD3 mAbs (47) . As pointed out by others (47) , this property of NK1 + T ceils may have important implications for the development of conventional CD4 + TCR-c~/fl + ceils of the Th2 cytokine profile, since, in many systems, Th2 cells arise preferentially (or exclusively) Figure 1 . Specuhtive coreceptor model for CD1 ligand recognition by NK1 + T cells. In this model, the highly conserved TCK-ot/B on NK1 + T cells reacts with the nonpolymorphic CD1 molecule. At the same time, the extracellular C-type lectin domain of NKI.1 interacts with a carbohydrate moiety on CD1 to stabilize TCR binding. By analogy with CD4 and CD8 on conventional T cells, NKI.1 could thus signal as a coreceptor via its putative cytoplasmic association with the tyrosine kinase p561ck. It is not known whether the peptide-binding groove of CD1 is occupied, and the putative carbohydrate moiety could be of either endogenous or exogenous origin. Note that NKI.1 is a homodimer and hence could theoretically cross-link TCR-CD1 complexes.
under conditions of stimulation where IL-4 is already present. Indeed, it has been shown recently that CD4 + cells with a CD62L l~ phenotype (a population that includes NK1 + T cells) are required to direct the in vitro differentiation of Th2 cells from naive CD4 + precursors (48) .
Unlike conventional NK cells, NK1 + T cells appear not to lyse NK-sensitive target calls such as YAC-1 when freshly isolated ex vivo; however, they are capable of redirected lysis of Fc receptor-bearing target cells in the presence of antibodies to the TCR-CD3 complex (11) . Furthermore, NK1 + T cells (like NK cells) can be induced to kill tumor ceils after exposure to cytokines such as IL-2 and IL-4 in vitro (44, 49, 50) or IL-12 in vivo (30) . Interestingly, even freshly isolated thymic NK1 + T cells are able to lyse normal cortical (CD4 +8 +) thymocytes, apparently via the Pas-mediated pathway (51) . Since cortical thymocytes express the putative NK1 + T cell ligand CD1 (52), it is possible that NK1 + T cells may play a role in thymic selection or homeostasis.
Are NKI + T Cells "Suppressor" Cells?
No discussion of NK1 + T cells would be complete without reforence to their possible relationship to suppressor cells. Indeed, the invariant Vot14-Jot281 rearrangement that is now known to be characteristic of most NK1 + T ceils was first identified as a conserved rearrangement in a panel of KLH-specific suppressor cell hybridomas (53) , and other suppressor T cell hybridomas specific for antigens such as DNP use the identical ot chain (54) . Although the actual mechanism of suppression mediated by such hybridomas is still not well defined, it is tempting to speculate that NK1 + T cells may in general be involved in negative regulatory functions, perhaps facilitated by their cytolytic activity and potential to secrete large amounts of inhibitory cytokines.
A more physiological regulatory function of NK1 + T cells relates to the supression of hemopoiesis. It has been known for many years that irradiated F1 mice frequently reject parental bone marrow grafts. The phenomenon, known as hybrid resistance, is genetically complex and involves the participation of NKI.1 + effector cells (55) . Whereas it was initially assumed that these effector cells are conventional NK cells, several studies clearly implicate NK1 + T cells in hybrid resistance (10, 56) . This issue is currently controversial, and it is possible that both NK and NK1 + T cells may be involved in the suppression of hemopoiesis (55) .
NKI + T Cells Expressing TCR-'y/$
This commentary has focused on the well-established subset of NK1 + T cells that expresses TCR-c,//~. However, in this issue of the journal, Arase et al. (57) describe a novel population of TCR-3,//~ + NK1 + T cells that is present in very low frequency in normal thymus. Interestingly, TCR~//~ + NK1 + T cells are increased dramatically in the thymus of CD3-~'-deficient mice, where, in contrast, mature TCRo~//~ + cells (indnding the NK1 + T subset) fail to develop. By analogy to conventional TCR-3d6 + cells present in the gut epithelium (58) , it is likely that thymic TCR-'y//~ + NK1 + T cells are able to develop in CD3-~'-deficient mice because the CD3~'-chain in their TCR complex can be substituted by the homologous FceRI ~/chain, which normally assodates with CD16 to form the high atfinity Fc receptor (59, 60) . In any event, it will be of considerable interest to further characterize this novel NKI.1 + TCR-3'//5 + subset in terms of its origin and function. Given the paucity of information concerning the physiological ligand recognized by conventional TCR-3,//~ cells, it will be particularly challenging to address the specificity of the NK1 § TCR-34/~ receptor. As a first approach, it will obviously be informative to investigate whether V gene usage is biased in these cells, as is the case for the TCR-ot/B + NK1 + T subset.
Concluding Remarks
NK1 + T calls represent a fascinating subset of TCR-ot/3 (and apparently TCR-3,//~) ceils with poorly defined ligand specificity. As outlined here, it appears likely that NK1 + T cells can develop independently in several extrathymic tissues (notably bone marrow and liver) as well as in the thymus. Because of their ability to secrete large amounts oflL-4 upon TCR engagement, NK1 + T cells may play a pivotal role in Thl/Th2 lineage commitment of conventional CD4 + T C R . -a / • + cells. Furthermore, the potential of NK1 + T cells to mediate target cell lysis under certain conditions may allow them to carry out other regulatory functions, such as the suppression of immune responses or of hemopoiesis. U1-timatdy, NK1 + T cells may turn out to be bona fide regulatory T cells that can even be discussed openly in public (61) .
